Form 8-K BeiGene, Ltd. For: Mar 08
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/26/2026
- Wall Street ends higher as tech rebounds before Nvidia results
- Oil settles down more than 3%; investors shrug off US sanctions on Iran
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- Six Flags to move headquarters from Charlotte to Arlington, Texas
- Wall Street ends higher as tech rebounds before Nvidia results
- Intuit (INTU) Tops Q4 EPS; Offers FY27 Guidance
- Oppenheimer Upgrades Capricor Therapeutics (CAPR) to Outperform 'on Approval Optimism'
- Dick's Sporting Goods (DKS) Misses Q2 EPS by 25c, Offers Guidance
BeiGene (BGNE) Files Parent Infringement Suit Against MSN Pharmaceuticals
March 8, 2024 6:08 AM ESTOn March 8, 2024, BeiGene (NASDAQ: BGNE) filed patent infringement suits under the Hatch-Waxman Act against Sandoz Inc. (Sandoz) and separately against MSN Pharmaceuticals, Inc. and MSN Laboratories Private Ltd. (collectively MSN) in the United States District Court for the District of New Jersey. The patent infringement suits are in... More
